Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://anyajgxq988970.blogerus.com/62489356/tirzepatide-a-new-frontier-in-diabetes-treatment